Lidocaine Patches: Clinical Uses
Lidocaine patches are primarily indicated for localized neuropathic pain, with strongest evidence supporting their use as first-line therapy for postherpetic neuralgia, and additional applications for myofascial pain, cancer-related neuropathic pain, and various peripheral neuropathies. 1, 2, 3
Primary Indications
Postherpetic Neuralgia (First-Line Therapy)
- Lidocaine patches demonstrate exceptional efficacy for postherpetic neuralgia with a number needed to treat (NNT) of 2, making them one of the most effective treatments available for this condition. 1, 4
- Approximately 60% of patients achieve moderate to complete pain relief with proper 12-hour daily application. 4, 5
- Significant pain reduction occurs at all time points from 4-12 hours compared to placebo, with benefits appearing as early as Day 7 in 66% of patients. 6, 5
- Early application during acute herpes zoster neuralgia may prevent progression to chronic postherpetic neuralgia in up to 63% of cases. 7
Localized Neuropathic Pain Syndromes
- Effective for painful diabetic polyneuropathy, particularly for nighttime foot pain. 4
- Demonstrated efficacy in HIV-associated peripheral neuropathy. 4
- Recommended by the National Comprehensive Cancer Network for cancer-related neuropathic and myofascial pain, with stronger evidence than other topical agents. 3
Musculoskeletal Pain
- Indicated for myalgias, arthralgias, and myofascial pain as part of localized therapy approaches. 3
- Effective for back pain management, providing both immediate and sustained relief when combined with cream formulations. 2
Application Protocol
Dosing and Administration
- Apply up to 3-4 patches simultaneously to intact skin covering the painful area. 2, 3, 4
- Standard regimen: 12 hours on, 12 hours off (within a 24-hour period). 4
- Available in 4% over-the-counter concentration or 5% prescription strength. 2, 3
- Can be applied to dorsal or plantar surfaces of affected areas. 2, 4
Combination Approach
- Lidocaine cream can be applied to areas where patches may not adhere well or to complement patch coverage, providing immediate relief while patches deliver sustained medication. 2
Safety Profile and Monitoring
Systemic Absorption
- Minimal systemic absorption occurs even with four patches applied over 24 hours, with highest measured blood levels at only 0.1 micrograms/ml. 3, 6
- Pharmacokinetic studies confirm systemic lidocaine levels remain within safe range. 2, 3
Adverse Effects
- Adverse reactions are rare, mild, and mostly limited to local skin reactions (rash or irritation). 3, 8
- Application to the head is tolerated less well compared to trunk and extremities, with significantly more adverse events reported. 9
Contraindications
- Advanced liver failure (hepatic impairment reduces lidocaine clearance by 60%). 2
- Broken or inflamed skin. 2, 3, 4
- Known hypersensitivity to amide anesthetics. 2, 3, 4
Critical Precautions
- Avoid excessive heat application over patches, as this increases systemic absorption. 2, 3, 4
- Remove patches before starting intravenous lidocaine therapy. 2, 3
- Avoid using within 4 hours of other local anesthetic interventions. 2, 3
- Monitor for signs of systemic absorption: dizziness, confusion, bradycardia, drowsiness, disorientation, muscle twitching. 2, 3, 4
When Lidocaine Patches Provide Inadequate Relief
Combination Pharmacotherapy
- Add gabapentin starting at 50-100 mg three times daily, titrating to 900-3600 mg daily for neuropathic pain components. 3, 4
- Consider pregabalin 50 mg three times daily, titrated to 100 mg three times daily if gabapentin fails. 1, 4
- Tricyclic antidepressants (nortriptyline, desipramine) starting at 10-25 mg, titrated to 50-150 mg can be added. 4
- The combination of morphine and gabapentin should be considered for possible additive effects at lower individual doses. 1
Alternative Topical Agents
- Capsaicin 8% patch provides pain relief lasting up to 90 days from single application. 4
- Capsaicin 0.075% cream has an NNT of 3.26 for postherpetic neuralgia. 1
- Topical diclofenac gel (1%) may provide relief for bone metastases pain. 3, 4
Non-Pharmacological Therapies
Common Pitfalls to Avoid
- Do not apply to broken or inflamed skin, as this dramatically increases systemic absorption and toxicity risk. 2, 3, 4
- Do not delay treatment in acute herpes zoster neuralgia—early application may prevent chronic postherpetic neuralgia development. 7
- Do not exceed 12 hours of continuous application to ensure adequate patch-free period and minimize skin irritation. 4
- Do not use in patients with advanced liver failure without careful monitoring, as lidocaine clearance is reduced by 60%. 2